Previous 10 | Next 10 |
SEATTLE and VANCOUVER, British Columbia , March 13, 2020 /PRNewswire/ -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine addiction, toda...
SEATTLE and VANCOUVER, British Columbia , March 12, 2020 /PRNewswire/ -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine addiction, announ...
SEATTLE and VANCOUVER, British Columbia , Feb. 6, 2020 /PRNewswire/ -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine addiction, today ...
Achieve Life Sciences (NASDAQ: ACHV ), University of Bristol, and Oracle (NYSE: ORCL ) announce the outcome of a study using Oracle's cloud infrastructure to improve the speed of drug discovery and development of new treatments. More news on: Achieve Life Sciences, Inc., Oracle Corporati...
SEATTLE and VANCOUVER, British Columbia , Jan. 13, 2020 /PRNewswire/ -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), University of Bristol , and Oracle Corporation (NYSE: ORCL) today announced the outcome of a study using Oracle's high-performance cloud infrastructure to potentiall...
Achieve Life Sciences, Inc. Announces Closing of $13.8 Million Underwritten Public Offering, Including Full Exercise of Overallotment Option Canada NewsWire SEATTLE and VANCOUVER, British Columbia, Dec. 19, 2019 SEATTLE and VANCOUVER, British Columbia , Dec. 19, 2019 ...
Achieve Life Sciences ( ACHV -34.1% ) is down on a robust 90x surge in volume in response to its $12M public offering of Class A & B units. More news on: Achieve Life Sciences, Inc., Healthcare stocks news, Stocks on the move, Read more ...
Gainers: Technical Communications (NASDAQ: TCCO ) +323% . More news on: Technical Communications Corporation, Venus Concept Inc., Iterum Therapeutics plc, Stocks on the move, Read more ...
Achieve Life Sciences (NASDAQ: ACHV ) announces an update on the cytisinicline clinical development program. More news on: Achieve Life Sciences, Inc., Healthcare stocks news, Stocks on the move, Read more ...
SEATTLE and VANCOUVER, British Columbia , Dec. 9, 2019 /PRNewswire/ -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine addiction, today ...
News, Short Squeeze, Breakout and More Instantly...
Achieve Life Sciences Inc. Company Name:
ACHV Stock Symbol:
NASDAQ Market:
Achieve Life Sciences Inc. Website:
2024-05-17 13:10:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
SEATTLE and VANCOUVER, British Columbia, May 17, 2024 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (NASDAQ:ACHV), a late-stage pharmaceutical...
SEATTLE and VANCOUVER, British Columbia, May 17, 2024 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine dependence, today announced data ...